Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.
about
Opioid agonist treatment for pharmaceutical opioid dependent peopleOpioid agonist treatment for pharmaceutical opioid dependent peopleBuprenorphine maintenance versus placebo or methadone maintenance for opioid dependenceQTc interval screening for cardiac risk in methadone treatment of opioid dependenceECG screening for preventing long QTc-related cardiac morbidity/mortality in methadone treated opioid addictsDrugs-Related Death Soon after Hospital-Discharge among Drug Treatment Clients in Scotland: Record Linkage, Validation, and Investigation of Risk-FactorsMortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studiesA review of a national training initiative to increase provider use of MAT to address the opioid epidemic.High levels of opioid analgesic co-prescription among methadone maintenance treatment clients in British Columbia, Canada: results from a population-level retrospective cohort studyGender differences in mortality and risk factors in a 13-year cohort study of street-recruited injecting drug usersImpact of lifetime opioid exposure on arterial stiffness and vascular age: cross-sectional and longitudinal studies in men and women.Meta-analysis of drug-related deaths soon after release from prison.Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research DatabaseBAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP.Sex differences amongst dependent heroin users: histories, clinical characteristics and predictors of other substance dependence.Examining non-AIDS mortality among people who inject drugs.Ethnic and genetic factors in methadone pharmacokinetics: a population pharmacokinetic studyNew developments in the management of opioid dependence: focus on sublingual buprenorphine-naloxone.Drug-related deaths and the sales of needles through pharmaciesA day-by-day investigation of changes in criminal convictions before and after entering and leaving opioid maintenance treatment: a national cohort study.Mortality among older adults with opioid use disorders in the Veteran's Health Administration, 2000-2011The impact of opioid substitution therapy on mortality post-release from prison: retrospective data linkage study.Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users.Redefining retention: recovery from the patient's perspective.Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: stability and correlates.Changes in somatic disease incidents during opioid maintenance treatment: results from a Norwegian cohort study.Take-home naloxone to prevent fatalities from opiate-overdose: Protocol for Scotland's public health policy evaluation, and a new measure to assess impactMortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10.Mortality of those who attended drug services in Scotland 1996-2006: record-linkage study.Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991-2012.Cost-effectiveness of diacetylmorphine versus methadone for chronic opioid dependence refractory to treatment.Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings.Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic systemThe Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject DrugsSustained release oral morphine as an alternative to methadone for the treatment of opioid-use disorder post Torsades de Pointes cardiac arrestGender differences in mortality among treated opioid dependent patients.The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting.Epidemiologic and molecular pathophysiology of chronic opioid dependence and the place of naltrexone extended-release formulations in its clinical management.Costs of health resource utilization among HIV-positive individuals in British Columbia, Canada: results from a population-level study.Impact of opioid substitution therapy for Scotland's prisoners on drug-related deaths soon after prisoner release.
P2860
Q24185775-4B828AF4-9384-48CF-8C37-18930D61D25AQ24194813-CD0CCFBB-5F81-4626-89AE-74B528068692Q24200539-914FA751-B019-4DC5-ADD0-41C2F4779D88Q24201880-E6CEA2EE-239E-4180-8703-ED114F695938Q24235379-127AC89F-3A69-4855-8586-7D92FA3A5D72Q28550704-5F358D4A-533A-46D8-9773-D1C037A5D9BFQ30234647-55290CF8-3E8D-431C-B2CF-7F038D523631Q30239840-F54E607A-B268-4507-AA50-B0413D6FEADEQ33661558-ACE8B999-1CB8-420F-AC3E-B7D2BF2261ECQ33719008-9D14CC3B-B2BC-46B1-AC16-136218529744Q33744915-9DFEECB0-3500-401B-8538-9CA494505529Q34204943-6531B8C2-4AC6-487C-B8C0-C72E722282D3Q34246166-5947DC21-CFEE-46CF-B930-71C72358FE6CQ34277168-9CA37BB5-B3D3-40DE-A8CF-678EC04BDE98Q34312133-7D1587CB-F069-4118-89D7-ECA781FB640EQ34585154-926B0BA8-F7FD-4119-BDC9-ED908FB9BD47Q34626158-56A784F8-C39D-4E70-A7E4-B79CABBCE5A8Q34952233-8ABE2D3D-8766-4464-94B6-63488B2FBC03Q34980340-52A3EAAB-E274-46E8-87B4-25E05A21627AQ35019120-B86A7D08-B700-4C68-A3AB-645A061DC2AEQ35027505-30877820-35D0-4B92-AFAF-98CA2263A75DQ35115444-54887BEB-33FF-450A-893D-1D1DE30DD0DDQ35167576-7FCA12C4-5035-4E22-A4F1-C7336453B1E5Q35178444-B7B5DB0F-E08D-4C20-948D-E6735AC61D0CQ35222561-D167B339-538C-4216-8915-931843BDD060Q35320110-BCFE97A9-B522-459F-B414-C24B4C370F1FQ35626439-216F178A-9947-4B6C-86C4-90ABA0350932Q35674032-FFA7A2F3-1A20-4E42-AA42-7A0413AE01A3Q35731338-DCAA1A4E-4911-469B-8D37-D7E8ED02EA48Q35795201-5C9FE871-124D-49DA-94A9-C7DE68A913D7Q35856799-1F0EE276-D8F7-46EC-A70B-01CB6F9223A7Q35871771-912D7BAD-6AAA-4A03-8C60-8D80F91B9CF3Q35995415-C16A7C30-9C30-4B6E-96BF-7744B9A71896Q36030512-0CA3DAF5-8DF1-463A-8855-29F1E5238EF7Q36080474-CF8C3502-D029-45CB-A54F-CFE9CF96FD7BQ36090298-251B6E74-C306-48BA-8415-5422B50EFCACQ36249096-0E240FAA-A39B-4D36-A04C-FB655B27A875Q36300075-A78DF974-4A1F-4333-9D2A-9610444B00BFQ36368335-791CFF09-0737-4E70-9F11-5B498B374EA6Q36554497-C7AA6710-74E2-46A8-AF4F-872E99D13952
P2860
Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Mortality among clients of a s ...... risk factors and lives saved.
@en
type
label
Mortality among clients of a s ...... risk factors and lives saved.
@en
prefLabel
Mortality among clients of a s ...... risk factors and lives saved.
@en
P50
P1476
Mortality among clients of a s ...... risk factors and lives saved.
@en
P2093
Tony Butler
P356
10.1016/J.DRUGALCDEP.2009.05.021
P407
P577
2009-07-15T00:00:00Z